There are no upcoming events at this time.

View All
View Full Calendar See All Updates

Get Email Updates

Energy and Commerce Committee

Letter

Filters
Sort Content By:
Subcommittees
Post Types
Categories

Letter to GAO Comptroller General Gene Dodaro Requesting Examination of DHS’s New Biosurveillance Pilot Program

08.08.2019

Excerpt: “We write to request that the Government Accountability Office examine the Department of Homeland Security’s deployment of a new biodetection technology system called BioDetection 21 to replace BioWatch, and the status of the DHS’s implementation of GAO’s prior recommendations concerning BioWatch.

...

This Committee has an ongoing bipartisan interest in biosurveillance programs that involve the Centers for Disease Control and Prevention, and the state and local public health laboratories.”

 

To read the full letter, click here.

Letter

Letter to USTR Lighthizer Regarding the Inclusion of Article 19.17 in the USMCA

08.06.2019

Excerpt: "As you may know, the effects of Section 230 and the appropriate role of such a liability shield have become the subject of much debate in recent years.  While we take no view on that debate in this letter, we find it inappropriate for the United States to export language mirroring Section 230 while such serious policy discussions are ongoing.  For that reason, we do not believe any provision regarding intermediary liability protections of the type created by Article 19.17 are ripe for inclusion in any trade deal going...

Letter

Letter to FDA requesting briefing on threat to U.S. heparin supply

07.30.2019

Excerpt: "As a former senior fellow for global health at the Council on Foreign Relations recently observed, 'Nearly 80 percent of the world’s heparin ingredient supply is made in China, which is why halving of the nation’s swine population should also be a major pharmaceutical concern for the world,'" the bipartisan Committee leaders wrote. "In advance of this potential supply problem, please have appropriate FDA staff provide a briefing to Committee staff on how the agency is monitoring the adequacy of the U.S. heparin supply, and on FDA’s plans to...

Letter

Letter to Acting Commissioner Sharpless Requesting an Update on the Drug Supply Chain

06.28.2019

Excerpt: "Pursuant to Rules X and XI of the U.S. House of Representatives, the Committee is continuing to examine the Food and Drug Administration's (FDA) ability to ensure the safety of the nation's drug supply. Earlier this year, we wrote to FDA concerning a series of recalls involving drugs manufactured overseas that contained trace amounts of known carcinogens. We appreciate the staff briefing FDA provided, and we are now writing to request additional information."

To view the letter, click HERE.

Letter

Letter to Comptroller General Gene Dodaro Requesting GAO Review of FDA’s Foreign Drug Inspection Program

06.28.2019

Excerpt: "The Committee has long held an interest in FDA’s ability to oversee medical products manufactured overseas and in the foreign offices FDA set up to improve its oversight of these and other products. Therefore, we request that GAO conduct a review of FDA’s drug inspection program."

To view the letter, click HERE.

Letter

Letters to six federal agencies today requesting briefings on the illicit flow of fentanyl into American communities

06.13.2019

Excerpt: “As overdose deaths involving fentanyl continue to rise, we remain concerned about the impact of this epidemic on the public health, and we are committed to identifying further solutions to stop the flow of deadly illicit fentanyl into our communities. Therefore, to assist the Committee’s investigation, please provide a briefing on these issues to Committee staff.”

To view the letters sent to the six agencies, click here: DHS, Department of State, DEA, FDA, ONDCP, and USPS.  

Letter

Letter to E&C Majority Reiterating Request for Medicare for All Hearing

05.21.2019

Excerpt: “On April 30th the House Rules Committee held a hearing on the Medicare for All Act of 2019, the Ways and Means Committee has confirmed the committee will hold a hearing, and tomorrow the House Budget Committee is holding a hearing on Medicare for All . However, this Committee has failed to be a leader on Medicare for All, even when other House Committees have taken the initiative to request reports on this policy and affirmatively state their intent to hold hearings on the Medicare for All proposal....

Letter

Letter to FCC Chairman Pai Regarding 5G Security

05.09.2019

Excerpt: “The ubiquitous deployment of broadband, including next generation technologies such as 5G, is a priority as we work to ensure every American has access to affordable, reliable, and high-speed internet. As our U.S. network operators, from the largest to the smallest, gear up for significant infrastructure buildout for 5G and other advanced technologies, security should be a critical consideration and associated rules and regulations should be as clear as possible.”

To view the full letter, click here.

Letter
Letter